Qianhai Health Holdings Limited released its Monthly Return for Equity Issuers covering the period ended 31 August 2026, confirming a stable capital structure and compliance with Hong Kong’s public float rules.

Authorised Share Capital • The company’s authorised capital remained unchanged at 500.00 million ordinary shares with a par value of HKD 0.40 each, equivalent to a registered share capital of HKD 200.00 million.

Issued and Treasury Shares • Issued shares (excluding treasury shares) closed the month at 169.45 million, identical to the prior month’s level, indicating no new share issuance, cancellation or buy-back activity in August. • The company held no treasury shares as at 31 August 2026.

Public Float Compliance • Management confirmed that the public float exceeded the Main Board’s minimum threshold of 25% of the issued share capital, ensuring continued compliance with Listing Rule 13.32D(1).

Capital Instruments and Other Movements • The filing reported no outstanding share option schemes, warrants, convertible securities, or other equity-linked agreements. • No movements were recorded under “Other Movements in Issued Shares and/or Treasury Shares.”

Governance Confirmation • Company Secretary Teresa Yip Tak Yung affirmed that all regulatory requirements and listing conditions were duly satisfied during the reporting period, and no new securities were issued or transferred that require additional disclosure.

Overall, Qianhai Health maintained a consistent share capital profile throughout August 2026, with full adherence to Hong Kong Stock Exchange regulations and no dilution to existing shareholders.